Please assess the completion status of the following clinical trial:

Trial Title: Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Acute exacerbation of COPD type I or II according to GOLD~* Ability to perform lung function tests~* Ability to take oral medication~Exclusion Criteria:~* Pregnant or lactating women, or women of childbearing age not using an acceptable method of contraception.~* Pretreatment ( \> 24 hours) with an antibiotic for the present exacerbation.~* Pretreatment with corticosteroids (\>30 mg for more than 4 days) for the present exacerbation.~* Progression or new radiographic abnormalities on the chest X-ray.~* Severe exacerbation that required mechanical ventilation.~* History of bronchiectasis~* Recent or unresolved lung malignancy.~* Other disease likely to require antibiotic therapy.~* Significant gastrointestinal or other conditions that may affect study drug absorption.~* Class III or IV congestive heart failure or stroke.~* Immunodeficiency disorders such as AIDS, humoral immune defect, ciliary dysfunction etc. and the use of immunosuppressive drugs (\>30 mg prednisolone maintenance dose or equivalent for more than 4 weeks).~* Cystic fibrosis~* Tuberculosis.~* Impaired renal function (creatinine clearance \< 20 ml/min).

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).